SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness. (2019)

First Author: Nguyen C

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.42042

Publication URI: https://www.repository.cam.ac.uk/handle/1810/294955

Type: Journal Article/Review